Skip to main content
. 2013 Sep;41(9):1703–1714. doi: 10.1124/dmd.113.052084

Fig. 8.

Fig. 8.

The mGlu5 ago-PAM metabolite M1 induces dose- and time-dependent increases in behavioral adverse effects in male Sprague-Dawley rats receiving a single administration (i.p., 30 mg/kg, n = 2), whereas the inactive metabolite M2 is devoid of AEs (i.p., 30 mg/kg, n = 2). Data represent mean ± S.E.M.